JP2012067099A5 - - Google Patents

Download PDF

Info

Publication number
JP2012067099A5
JP2012067099A5 JP2011197386A JP2011197386A JP2012067099A5 JP 2012067099 A5 JP2012067099 A5 JP 2012067099A5 JP 2011197386 A JP2011197386 A JP 2011197386A JP 2011197386 A JP2011197386 A JP 2011197386A JP 2012067099 A5 JP2012067099 A5 JP 2012067099A5
Authority
JP
Japan
Prior art keywords
composition
acth
ala
lys
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011197386A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012067099A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012067099A publication Critical patent/JP2012067099A/ja
Publication of JP2012067099A5 publication Critical patent/JP2012067099A5/ja
Pending legal-status Critical Current

Links

JP2011197386A 2004-10-27 2011-09-09 副腎皮質刺激ホルモンアナログおよびこれに関連する方法 Pending JP2012067099A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62243604P 2004-10-27 2004-10-27
US60/622,436 2004-10-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007539117A Division JP2008518026A (ja) 2004-10-27 2005-10-27 副腎皮質刺激ホルモンアナログおよびこれに関連する方法

Publications (2)

Publication Number Publication Date
JP2012067099A JP2012067099A (ja) 2012-04-05
JP2012067099A5 true JP2012067099A5 (enExample) 2012-08-02

Family

ID=36336951

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007539117A Ceased JP2008518026A (ja) 2004-10-27 2005-10-27 副腎皮質刺激ホルモンアナログおよびこれに関連する方法
JP2011197386A Pending JP2012067099A (ja) 2004-10-27 2011-09-09 副腎皮質刺激ホルモンアナログおよびこれに関連する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007539117A Ceased JP2008518026A (ja) 2004-10-27 2005-10-27 副腎皮質刺激ホルモンアナログおよびこれに関連する方法

Country Status (13)

Country Link
US (4) US7919577B2 (enExample)
EP (2) EP1814574A4 (enExample)
JP (2) JP2008518026A (enExample)
KR (3) KR101242543B1 (enExample)
CN (2) CN101947310A (enExample)
AU (2) AU2005305157B2 (enExample)
CA (1) CA2584221A1 (enExample)
IL (1) IL182818A0 (enExample)
MX (1) MX2007004676A (enExample)
NZ (1) NZ554559A (enExample)
RU (2) RU2407751C2 (enExample)
SG (1) SG156680A1 (enExample)
WO (1) WO2006052468A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006052468A2 (en) 2004-10-27 2006-05-18 University Of Denver Adrenocorticotropic hormone analogs and related methods
RU2010113992A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение урокортина и кортиколиберина в качестве терапевтических средств
US8524664B2 (en) 2011-06-02 2013-09-03 Colorado Seminary, Which owns and Operates The Univeristy of Denver Methods of treating overproduction of cortisol using ACTH antagonist peptides
WO2014168721A2 (en) * 2013-04-12 2014-10-16 Tufts Medical Center Methods and systems for designing and/or characterizing soluble lipidated ligand agents
CN104277105B (zh) * 2013-07-12 2017-12-12 国家纳米科学中心 抑制β淀粉样蛋白聚集和毒性的多肽抑制剂及其应用
CN103724427B (zh) * 2013-11-29 2016-09-28 青岛康原药业有限公司 一种精制促皮质素的方法
AU2014368789B2 (en) * 2013-12-19 2020-04-16 Instituut Voor Landbouw- En Visserijonderzoek (Ilvo) Quantification of glucocorticoids in fish scales as biomarkers for chronic stress
CA2940242C (en) 2014-02-20 2026-01-13 H. Lundbeck A/S Anti-acth antibodies and use thereof
ES3057010T3 (en) 2014-12-19 2026-02-25 H Lundbeck As Humanized anti-acth antibodies and use thereof
CN104530219A (zh) * 2014-12-23 2015-04-22 青岛康原药业有限公司 一种精制促皮质素的方法
JP6752223B2 (ja) 2015-04-16 2020-09-09 アルダー・バイオファーマシューティカルズ・インコーポレーテッド 羞明を処置、予防、または阻害するための抗ｐａｃａｐ抗体及びそれらの抗原結合性断片の使用
WO2017127827A1 (en) 2016-01-22 2017-07-27 Tufts Medical Center Compounds and methods for treating inflammation
CN105669856A (zh) * 2016-02-13 2016-06-15 王大勇 一种基因重组长效人促肾上腺皮质激素及其制备方法
IL302705A (en) 2016-03-01 2023-07-01 Immatics Biotechnologies Gmbh Peptides, combinations of peptides, cell-based drugs for use in immunotherapy against bladder cancer and other types of cancer
CA3020839A1 (en) 2016-04-15 2017-10-19 Alder Biopharmaceuticals, Inc. Anti-pacap antibodies and uses thereof
CN106478771A (zh) * 2016-10-09 2017-03-08 李世军 一种氨基酸神经四肽的合成方法
WO2018118115A1 (en) * 2016-12-19 2018-06-28 Eton Pharmaceuticals, Inc. Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
US11338018B2 (en) 2016-12-19 2022-05-24 Harrow Ip, Llc Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
CN110698557B (zh) * 2019-11-06 2021-06-18 郑州伊美诺生物技术有限公司 Acth突变体、重组蛋白及其应用，以及含有该acth重组蛋白的试剂盒
WO2022217395A1 (zh) * 2021-04-12 2022-10-20 南京汉欣医药科技有限公司 一种高纯的人促肾上腺皮质激素或其类似物及其规模化制备方法
US12433936B2 (en) 2021-04-12 2025-10-07 Nanjing Hanxin Pharmaceutical Technology Co., Ltd. High-purity adrenocorticotropic hormone analogue and a large-scale preparation method thereof
CN120420414A (zh) * 2024-02-04 2025-08-05 南京汉欣医药科技有限公司 含有人工合成的促皮质素类似物的组合物、其制备方法以及其用途

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6A (en) * 1836-08-10 Thomas Blanchard Machine for forming end pieces of plank blocks for ships
US4415546A (en) 1981-05-12 1983-11-15 Janakiraman Ramachandran Biologically active analogs of ACTH and radioimmuno assay therefor
US4457864A (en) 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin
US4649191A (en) 1984-05-10 1987-03-10 Gibson-Stephens Neuropharmaceuticals, Inc. Conformationally constrained alpha-melanotropin analogs with specific central nervous system activity
ATE84420T1 (de) 1986-02-03 1993-01-15 University Patents Inc Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
US5674839A (en) 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
US5049547A (en) 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
US4948580A (en) 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
JPH02258718A (ja) 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5189018A (en) 1991-08-19 1993-02-23 Wayne State University Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma
JPH08503950A (ja) 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
EP0681491B1 (en) 1993-01-29 2000-12-13 Aradigm Corporation Intrapulmonary delivery of hormones
US5554380A (en) 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
ES2151079T3 (es) 1994-09-09 2000-12-16 Takeda Chemical Industries Ltd Preparacion de liberacion sostenida que contiene una sal metalica de un peptido.
US5731408A (en) 1995-04-10 1998-03-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
WO1996040072A2 (en) 1995-06-07 1996-12-19 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of human growth hormone
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US6346390B1 (en) * 1996-03-08 2002-02-12 Receptron, Inc. Receptor derived peptides involved in modulation of response to ligand binding
GB9606016D0 (en) 1996-03-22 1996-05-22 Smithkline Beecham Plc Novel use
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US5942243A (en) 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
TW577759B (en) 1997-04-18 2004-03-01 Ipsen Pharma Biotech Sustained release compositions in the form of microcapsules or implants and the process for their preparation
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
EP1087989A1 (en) 1998-06-26 2001-04-04 Pfizer Products Inc. Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon
US6875741B2 (en) * 1998-09-02 2005-04-05 Renuka Pillutla Insulin and IGF-1 receptor agonists and antagonists
CA2377369A1 (en) 1999-06-04 2000-12-14 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists
IES990700A2 (en) 1999-08-18 2001-08-22 Kinerton Ltd Process to make a sustained release formulation
US6056955A (en) 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
WO2001095935A1 (en) 2000-01-20 2001-12-20 Ottawa Health Research Institute Immunostimulatory nucleic acids for inducing a th2 immune response
AU2001257129A1 (en) 2000-04-21 2001-11-07 Advanced Research And Technology Institute, Inc. Novel pharmacotherapeutic process and composition for central nervous system disorders
WO2002023184A1 (en) 2000-09-13 2002-03-21 Eleanor Roosevelt Institute Method for treatment of insulin resistance in obesity and diabetes
AU2002243438A1 (en) 2000-10-25 2002-07-24 Mayo Foundation For Medical Education And Research Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
US6818613B2 (en) 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins
CN1863572A (zh) 2003-08-04 2006-11-15 阿尔扎公司 提高药剂经皮流通量的方法和装置
AU2004289362A1 (en) 2003-11-10 2005-05-26 Angiotech International Ag Intravascular devices and fibrosis-inducing agents
US20050147581A1 (en) 2003-11-19 2005-07-07 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes having improved stability and therapeutic use of the same
WO2006052468A2 (en) 2004-10-27 2006-05-18 University Of Denver Adrenocorticotropic hormone analogs and related methods

Similar Documents

Publication Publication Date Title
JP2012067099A5 (enExample)
US12285460B2 (en) Pharmaceutical compositions
RU2010135499A (ru) Аналоги адренокортикотропного гормона и относящиеся к ним методы
KR102092206B1 (ko) 장기-작용성 glp-1/글루카곤 수용체 작용제
JP6204369B2 (ja) カルシウム模倣薬およびその使用方法
JP2016518351A5 (enExample)
JP2016515620A5 (enExample)
JP2016501204A5 (enExample)
US20240190914A1 (en) Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
FI3356386T3 (fi) Melanokortiini-4-reseptoripolkuun liittyvien häiriöiden hoitamismenetelmä
JP2008518026A5 (enExample)
JP2016084357A (ja) エンドモルフィンのμオピオイド受容体アゴニスト類似体
TW201808346A (zh) 長效調酸素調配物及其產生與投與方法
HK40073416A (en) Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
WO2024209050A1 (en) Gip activity modulators and orthostatic intolerance
HK40046859A (en) Pharmaceutical compositions
HK1220702B (en) Pharmaceutical compositions